Identification of RIP1 kinase as a specific cellular target of necrostatins
Top Cited Papers
- 13 April 2008
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 4 (5) , 313-321
- https://doi.org/10.1038/nchembio.83
Abstract
Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their respective ligands under conditions where apoptotic execution is prevented. Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphological features as unregulated necrotic death. Here we report that necrostatin-1, a previously identified small-molecule inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor–associated adaptor kinase RIP1 in vitro. We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1. In addition, we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1. Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.Keywords
This publication has 48 references indexed in Scilit:
- Necrostatin‐1 protects against glutamate‐induced glutathione depletion and caspase‐independent cell death in HT‐22 cellsJournal of Neurochemistry, 2007
- Necrostatin: A Potentially Novel Cardioprotective Agent?Cardiovascular Drugs and Therapy, 2007
- Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF SignalingCurrent Biology, 2007
- Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-κB, JNK1, p53 and WOX1 during stress responseBMC Molecular Biology, 2007
- Distinct Signaling Pathways in TRAIL- versus Tumor Necrosis Factor-Induced ApoptosisMolecular and Cellular Biology, 2006
- A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analoguesProceedings of the National Academy of Sciences, 2006
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983